Method for diagnosing a neurodegenerative disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9896729
APP PUB NO 20150252421A1
SERIAL NO

14241646

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods of assessing whether a subject has or is likely to develop a neurodegenerative disease comprising determining whether the subject has a mutation in the C9orf72 gene wherein said mutation prevents or disrupts C9orf72 expression relative to expression in a reference from subjects without the mutation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICESOFFICE OF TECHNOLOGY TRANSFER 6011 EXECUTIVE BLVD SUITE 325 ROCKVILLE MD 20852

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hardy, John Chelmsford, GB 17 99
Heutink, Peter Tübingen, DE 5 19
Morris, Huw Cardiff, GB 2 12
Pickering-Brown, Stuart Manchester, GB 2 12
Singleton, Andrew B Poolesville, US 2 12
Tienari, Pentti Helsinki, FI 2 12
Traynor, Bryan Bethesda, US 2 12

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00